The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer

---

Atıf İçin Kopyala

Aras G., Gultekin S. S., KÜÇÜK N. Ö.

NUCLEAR MEDICINE COMMUNICATIONS, cilt.29, sa.10, ss.880-884, 2008 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 29 Sayı: 10
• Basım Tarihi: 2008
• Doi Numarası: 10.1097/mnm.0b013e328308e079
• Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.880-884
• Anahtar Kelimeler: antithyroglobulin antibody, differentiated thyroid carcinoma, progressive disease, thyroglobulin, SERUM THYROGLOBULIN, FOLLOW-UP, AUTOANTIBODIES, PREVALENCE, CARCINOMA
• Ankara Üniversitesi Adresli: Evet

Özet

Aim To evaluate retrospectively the additive clinical value of combined thyroglobulin (Tg) and antithyroglobulin antibody (TgAb) measurements to define recurrent and persistent disease in patients with differentiated thyroid cancer.